Changes of carbohydrate and lipid metafbolism and c-reactive protein in patients with ischemic heart disease and fatty hepatose
DOI:
https://doi.org/10.11603/mcch.2410-681X.2016.v0.i4.7252Keywords:
ischemic heart disease, non-alcoholic fatty liver disease, lipid metabolism, carbohydrate metabolism, C-reactive protein.Abstract
The aim of the study was to detect changes in lipid and carbohydrate metabolism and the level of C-reactive protein in patients with ischemic heart disease, combined with non-alcoholic fatty liver disease. Widespread ischemic heart disease combined with non-alcoholic fatty liver disease requires finding mutual pathogenetic mechanisms for improving the diagnosis and treatment optimization to improve the course and prognosis of these comorbid diseases. Patients with non-alcoholic fatty liver disease must be classified as high-risk population.
References
Miokardyt: vyznachennia, klasyfikatsiia, standarty diahnostyky ta likuvannia : metod. rek. / In-t kardiolohii im. M. D. Strazheska AMN Ukrainy, Ukr. tsentr nauk. med. inform. i patent.-litsenz. roboty ; uklad. : V. M. Kovalenko, D. V. Riabenko, N. O. Solobiukova, O. V. Onyshchenko. – Kyiv. : [b.v.], 2011. – 40 s.
Stepanov Iu. M. Klinicheskie osobennosti techeniia nealkogolnogo steatogepatita v zavisimosti ot soputstvuiushchikh zabolevanii / Iu. M. Stepanov, A. Iu. Filippova // Suchasna gastroenterologіia. – 2006. – 29, № 3. – S. 4–7.
The natural history of nonalcoholic fatty liver disease: a population-based cohort study / L. A. Adams, J. F. Lymp, J. St Sauver [et al.] // Gastroenterology. – 2005. – 129. – P. 113–121.
The diagnosis and management of nonalcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association / N. Chalasani, Z. Younossi, J. E. Lavine [et al.] // Hepatology. – 2012. – 55. – P. 2005–2023.
Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States / M. R. Charlton, J. M. Burns, R. A. Pedersen [et al.] // Gastroenterology. – 2011. – 141. – P. 1249–1253.
Long-term follow-up of patients with NAFLD and elevated liver enzymes / M. Ekstedt, L. E. Franzen, U. L. Mathiesen [et al.] // Hepatology. – 2006. – 44. – P. 865–873.
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement / S. M. Grundy, J. I. Cleeman, S. R. Daniels [et al.] // Circulation. – 2005. – 112. – P. 2735–2752.
Management of nonalcoholic fatty liver disease and steatohepatitis / T. A. Le, R. Loomba // J. Clin. Exp. Hepatol. – 2012. – 2. – P. 156–173.
Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease / R. Lomonaco, C. Ortiz-Lopez, B. Orsak [et al.] // Hepatology. – 2012. – 55. – P. 1389–1397.
Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis / R. Loomba, M. Abraham, A. Unalp [et al.] // Hepatology. – 2012. – 56. – P. 943–951.
Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients / M. Noureddin, K. P. Yates, I. A. Vaughn [et al.] // Hepatology. – 2013. – 58. – P. 1644–1654.
Endpoints and clinical trial design for nonalcoholic steatohepatitis / A. J. Sanyal, E. M. Brunt, D. E. Kleiner [et al.] // Hepatology. – 2011. – 54. – P. 344–353.
Randomized trial of exercise effect on intra hepatic triglyceride content and lipid kinetics in non alcoholic fatty liver disease / S. Sullivan, E. P. Kirk, B. Mittendorfer [et al.] // Hepatology. – 2012. – 55. – P. 1738–1745.
Vernon G. Systematic review: the epidemiology and natural history of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in adults / G. Vernon, A. Baranova, Z. M. Younossi Aliment // Pharmacol. Ther. – 2011. – 34. – P. 274–285.
